Canopy Growth (CGC) Cash from Financing Activities (2019 - 2025)

Canopy Growth (CGC) reported Cash from Financing Activities of $204.9 million for Q4 2025, up 1051.17% on a YoY basis from $17.8 million in Q4 2024, and up 1015.35% sequentially from $18.4 million in Q2 2025.

Canopy Growth (CGC) Cash from Financing Activities (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Cash from Financing Activities data on file, last reported at $204.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 1051.17% year-over-year to $204.9 million; the trailing twelve-month figure through Dec 2025 stood at $267.0 million (up 109.76% YoY), and the FY2026 full-year result was $242.4 million, up 133.96% from the prior year.
  • Cash from Financing Activities rose to $204.9 million in Q4 2025, from $18.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $786.6 million in Q1 2021 to a low of -$204.5 million in Q3 2023.
  • A 5-year average of $40.7 million and a median of -$273368.7 in 2021 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities slumped 36245.01% in 2022 and surged 14591.67% in 2023, its largest moves.
  • Tracing CGC's Cash from Financing Activities over 5 years: stood at $272114.3 in 2021, then plunged by 36245.01% to -$98.4 million in 2022, then jumped by 50.54% to -$48.6 million in 2023, then surged by 55.71% to -$21.5 million in 2024, then surged by 1051.17% to $204.9 million in 2025.
  • Business Quant data shows CGC's Cash from Financing Activities at $204.9 million in Q4 2025, $18.4 million in Q2 2025, and -$21.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 204.94 Mn
Dec 31, 2025 204.94 Mn
Jun 30, 2025 18.37 Mn
Jun 30, 2025 18.37 Mn
Dec 31, 2024 -21.55 Mn
Dec 31, 2024 -21.55 Mn
Sep 30, 2024 65.20 Mn
Sep 30, 2024 65.20 Mn
Jun 30, 2024 77.34 Mn
Jun 30, 2024 77.34 Mn
Mar 31, 2024 6.28 Mn
Mar 31, 2024 6.28 Mn
Dec 31, 2023 -48.65 Mn
Dec 31, 2023 -48.65 Mn
Sep 30, 2023 -204.53 Mn
Sep 30, 2023 -204.53 Mn
Jun 30, 2023 -99.09 Mn
Jun 30, 2023 -99.09 Mn
Mar 31, 2023 93.37 Mn
Mar 31, 2023 93.37 Mn